Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

Document Details

Form

ARS

Filing Date

Mar 31, 2026

Document Date

Dec 27, 2025

Form Description

An annual report to security holders

Filing Group

Annual Filings

Company

Charles River Laboratories International, Inc.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filing Formats

View HTML

Download PDF

Download DOC

Featured Reports

2025 Annual Report
View PDF
Print PDF

Charles River Corporate Citizenship Report
View PDF
Print PDF